SEPTONIQ Trademark

Trademark Overview


On Friday, December 1, 2023, a trademark application was filed for SEPTONIQ with the United States Patent and Trademark Office. The USPTO has given the SEPTONIQ trademark a serial number of 98294239. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Saturday, June 29, 2024. This trademark is owned by Heraeus Medical GmbH. The SEPTONIQ trademark is filed in the Medical Instrument Products category with the following description:

Drug delivery catheters; Drug delivery devices sold empty, namely, drug-eluting catheters
septoniq

General Information


Serial Number98294239
Word MarkSEPTONIQ
Filing DateFriday, December 1, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateSaturday, June 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDrug delivery catheters; Drug delivery devices sold empty, namely, drug-eluting catheters

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, December 1, 2023
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameHeraeus Medical GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressWehrheim 61273
DE

Trademark Events


Event DateEvent Description
Friday, December 1, 2023NEW APPLICATION ENTERED
Sunday, February 25, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 28, 2024ASSIGNED TO EXAMINER
Saturday, June 29, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Saturday, June 29, 2024SUSPENSION LETTER WRITTEN
Saturday, June 29, 2024LETTER OF SUSPENSION E-MAILED
Thursday, September 26, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED